Phil Skolnick - Jan 27, 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Chief Scientific Officer
Signature
/s/ Phil Skolnick
Stock symbol
OPNT
Transactions as of
Jan 27, 2023
Transactions value $
-$9,725
Form type
4
Date filed
1/31/2023, 03:19 PM
Previous filing
Jan 9, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale -$9.72K -480 -2.18% $20.26 21.5K Jan 27, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.